Entity Details

Primary name ITPA_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ9BY32
EntryNameITPA_HUMAN
FullNameInosine triphosphate pyrophosphatase
TaxID9606
Evidenceevidence at protein level
Length194
SequenceStatuscomplete
DateCreated2003-04-23
DateModified2021-06-02

Ontological Relatives

GenesITPA

GO terms

Show/Hide Table
GOName
GO:0000166 nucleotide binding
GO:0005654 nucleoplasm
GO:0005737 cytoplasm
GO:0005829 cytosol
GO:0006193 ITP catabolic process
GO:0006195 purine nucleotide catabolic process
GO:0009143 nucleoside triphosphate catabolic process
GO:0009204 deoxyribonucleoside triphosphate catabolic process
GO:0035529 NADH pyrophosphatase activity
GO:0035870 dITP diphosphatase activity
GO:0036218 dTTP diphosphatase activity
GO:0042802 identical protein binding
GO:0043231 intracellular membrane-bounded organelle
GO:0046872 metal ion binding
GO:0047429 nucleoside-triphosphate diphosphatase activity
GO:0051276 chromosome organization

Subcellular Location

Show/Hide Table
Subcellular Location
Cytoplasm

Domains

Show/Hide Table
DomainNameCategoryType
IPR002637 Ham1-like proteinFamilyFamily
IPR027502 Inosine triphosphate pyrophosphataseFamilyFamily
IPR029001 Inosine triphosphate pyrophosphatase-likeFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
613850 OMIMInosine triphosphate pyrophosphohydrolase deficiency (ITPAD)A common inherited condition characterized by the abnormal accumulation of inosine triphosphate in erythrocytes. It might have pharmacogenomic implications and be related to increased drug toxicity of purine analog drugs. The disease is caused by variants affecting the gene represented in this entry. Three different human populations have been reported with respect to their ITPase activity: high, mean (25% of high) and low activity. The variant Thr-32 is associated with complete loss of enzyme activity, may be by altering the local secondary structure of the protein. Heterozygotes for this polymorphism have 22.5% of the control activity: this is consistent with a dimeric structure of the enzyme.
616647 OMIMDevelopmental and epileptic encephalopathy 35 (DEE35)A form of epileptic encephalopathy, a heterogeneous group of severe childhood onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE35 is characterized by onset of seizures in the first months of life associated with essentially no normal development. Many patients die in early childhood. The disease is caused by variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB00993 AzathioprineDrugbanksmall molecule
DB04272 Citric acidDrugbanksmall molecule

Interactions

1 interaction

InteractorPartnerSourcesPublicationsLink
ITPA_HUMANITPA_HUMANBioGRID, IntAct25416956 32296183 details